Vitality Watch

Dossier pubmed review 01-aug-2026
Narrative review or expert overview without new data

Cardiometabolic Aging Driven by Multi-Organ Crosstalk: Mechanisms and Therapeutic Strategies.

Key claim: Cardiac aging is a systemic product of pathological multi-organ crosstalk that converges on oxidative stress, impaired autophagy, and cellular senescence, and may be delayed by targeting nodal points such as senolytics, myokine mimetics, gut microbiota modulation, RAAS/SGLT2 inhibitors, and integrated lifestyle strategies.

Abstract

Cardiac senescence is not an isolated organ decline but a systemic consequence driven by pathological crosstalk between the heart and its peripheral metabolic organs. In this review, we discard the traditional organ-centric perspective and construct an integrated framework around multi-organ crosstalk axes, including the epicardial adipose tissue-heart axis, the skeletal muscle-heart axis, the gut-heart axis, and the kidney-heart axis. For each axis, we dissect the local molecular mediators-inflammatory cytokines, lipotoxic metabolites, microbiota-derived compounds such as trimethylamine N-oxide (TMAO), renin-angiotensin-aldosterone system (RAAS) effectors, and extracellular vesicle (EV) cargoes-and illustrate how they converge onto common pathways of oxidative stress, impaired autophagy, and cellular senescence. Importantly, we emphasize that these signals do not operate in isolation; they act synergistically through the circulation, converting local organ dysfunction into systemic cardiac aging via convergence onto shared senescence pathways. By redefining aging as a potentially modifiable multi-organ crosstalk, we propose emerging nodal points-senolytics, myokine mimetics, gut microbiota modulation, RAAS/sodium-glucose cotransporter 2 (SGLT2) inhibitors, and integrated lifestyle strategies-to block pathological crosstalk and delay cardiovascular aging. This framework shifts the research focus from isolated organs to systemic multi-organ crosstalk, providing new insights into cardiometabolic aging.

Why this matters

The review consolidates cardiac aging as a systemic output of adipose–heart, muscle–heart, gut–heart, and kidney–heart signaling converging on the same three mechanistic substrates the vault already tracks: oxidative/mitochondrial stress, impaired autophagy, and cellular senescence. It bridges several previously siloed mechanism pages (vascular aging, gut microbiota, adipose senescence, myokines, Klotho) into a shared cardiometabolic-aging network and names candidate nodal interventions (senolytics, myokine mimetics, microbiota modulation, RAAS/SGLT2 inhibitors) whose biology is drawn from preclinical crosstalk models rather than cardiac-endpoint human trials.

Source

Link

Briefing card

Cardiometabolic Aging Driven by Multi-Organ Crosstalk: Mechanisms and Therapeutic Strategies.
Stage: review · pubmed · 01-aug-2026

Cardiac aging is a systemic product of pathological multi-organ crosstalk that converges on oxidative stress, impaired autophagy, and cellular senescence, and may be delayed by targeting nodal points such as senolytics, myokine mimetics, gut microbiota modulation, RAAS/SGLT2 inhibitors, and integrated lifestyle strategies.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.3390/ijms27156881

build build 880 · 2bcef25 · 2026-11-18